Core Viewpoint - The company is closely monitoring developments in the international small nucleic acid field and is tracking the application progress of small nucleic acid drugs [1] Group 1: Core Business Focus - The company's core business is focused on the research, development, production, and sales of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates [1] - Key products include sodium cytidine diphosphate, ribavirin, cytarabine hydrochloride, and cytosine, which are widely used in antiviral, antitumor, and neurological medications [1] Group 2: Health and Functional Food Market - The company is actively expanding into the health functional food raw material market, with main products including L-α-glycerophosphocholine, coenzyme Q10, monohydrate creatine, and L-carnitine [1] Group 3: Future Strategy - The company plans to closely follow market demand changes and continuously increase R&D investment to enhance operational performance and intrinsic value [1]

Core Viewpoint - The company, Tuoxin Pharmaceutical, emphasizes its strong position in the antiviral sector with a rich product portfolio and technological expertise in the development, production, and sales of pharmaceutical health products [1] Group 1: Company Overview - Tuoxin Pharmaceutical is identified as a high-tech enterprise focused on the research, development, production, and sales of pharmaceutical health products [1] - The company has a significant product reserve in the antiviral field, showcasing its capability and experience in this area [1] Group 2: Key Products - The core product, Ribavirin raw material, is highlighted as an important component of antiviral drugs and is classified as a broad-spectrum, potent antiviral medication [1] - Additionally, the company produces Cytidine and 5-Fluorouracil, which are key intermediates for synthesizing various antiviral drugs [1]

Core Viewpoint - The company, Tuoxin Pharmaceutical, focuses on the research, production, and sales of nucleoside (acid) raw materials and pharmaceutical intermediates, with a commitment to expanding its product offerings in the antiviral and antitumor sectors [1] Group 1: Company Focus and Products - The company and its subsidiaries specialize in nucleoside (acid) raw materials and pharmaceutical intermediates [1] - Main products include cytidine sodium, ribavirin, cytarabine hydrochloride, and cytosine, which are used in antiviral, antitumor, and neurological medications [1] Group 2: Future Development Plans - The company plans to continue deepening its core areas, increasing research and development efforts in nucleoside (acid) products for antitumor and antiviral applications [1] - There is an active strategy to expand into the broader health sector while striving for a full industry chain breakthrough from intermediates to raw materials and formulations [1]

Core Viewpoint - The company focuses on the research, production, and sales of nucleoside (acid) pharmaceutical intermediates and active pharmaceutical ingredients, primarily in the fields of antiviral, antitumor, and neurological medications [1] Company Overview - The main products of the company include: - Cytidine sodium - Cytidine - Acyclidine - Cytarabine hydrochloride - Adefovir dipivoxil - Ribavirin - Inosine - Acyclovir - Cytosine - 5-Fluorouracil - Cytidine - Uridine [1] Market Focus - The company is currently not involved in the development of vaccines or treatments related to the epidemic of Chikungunya virus [1]